avrg: GSE58827: Dynamics of the Mouse Liver
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfatc3 | mm10_v2_chr8_+_106059562_106059623 | -0.35 | 3.5e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_58670358 Show fit | 9.29 |
ENSMUST00000057270.7
|
pancreatic lipase |
|
chr15_+_10249560 Show fit | 8.93 |
ENSMUST00000134410.1
|
prolactin receptor |
|
chr1_+_88087802 Show fit | 5.85 |
ENSMUST00000113139.1
|
UDP glucuronosyltransferase 1 family, polypeptide A8 |
|
chr7_+_26808880 Show fit | 5.79 |
ENSMUST00000040944.7
|
cytochrome P450, family 2, subfamily g, polypeptide 1 |
|
chr3_-_75270073 Show fit | 5.59 |
ENSMUST00000039047.4
|
serine (or cysteine) peptidase inhibitor, clade I, member 2 |
|
chr15_+_10223974 Show fit | 5.42 |
ENSMUST00000128450.1
ENSMUST00000148257.1 ENSMUST00000128921.1 |
prolactin receptor |
|
chr10_-_109010955 Show fit | 5.41 |
ENSMUST00000105276.1
ENSMUST00000064054.7 |
synaptotagmin I |
|
chr19_+_52264323 Show fit | 5.29 |
ENSMUST00000039652.4
|
insulin I |
|
chr10_+_4611971 Show fit | 4.98 |
ENSMUST00000105590.1
ENSMUST00000067086.7 |
estrogen receptor 1 (alpha) |
|
chr19_-_40073731 Show fit | 4.66 |
ENSMUST00000048959.3
|
cytochrome P450, family 2, subfamily c, polypeptide 54 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 14.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.6 | 9.9 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.6 | 6.2 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.6 | 5.9 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.2 | 5.8 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
1.4 | 5.7 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 5.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.5 | 5.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.8 | 5.0 | GO:0060523 | Sertoli cell proliferation(GO:0060011) prostate epithelial cord elongation(GO:0060523) |
0.5 | 4.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 49.1 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 7.9 | GO:0009986 | cell surface(GO:0009986) |
0.3 | 5.4 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 5.0 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.3 | 4.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.4 | 3.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 2.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.3 | 2.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 2.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 14.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.3 | 13.0 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.5 | 9.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 8.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.2 | 6.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 5.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
1.4 | 5.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 5.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 5.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 5.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 8.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 4.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 3.6 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 3.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 3.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 3.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 3.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 2.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 19.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.7 | 14.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 10.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.8 | 9.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.5 | 5.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 4.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 4.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 3.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 3.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |